medline.ch Respirationstrakt Neoplasie

	Soxataltinib, a highly selective CNS-penetrant RET inhibitor demonstrates durable activity in RET fusion-positive non-small cell lung cancer phase 2 study. J Thorac Oncol Xiong A, Meng X, Li X, Zhang Y, Yang N, Yu Q, Tan L, Wang Q, Wang Y, Liu B, Luo H, Wang Y, Huang D, Zhang Y, Ye F, Fang J, Zhao M, Wang Y, Wang J, Zhu Y, Zhang Y, Zhou C. PMID: 42988049 [PubMed - as supplied by publisher]
	Adverse events in placebo arms of phase III lung cancer trials: a systematic review and meta-analysis. Lung Cancer Zhang J, Chen W, Mi L, Sun Y, Ji H, Zhang N, Chen Q. PMID: 42987631 [PubMed - as supplied by publisher]
	N-heterocyclic engineering of covalent organic framework (COF)-microenvironments for the development of enzyme-based biosensor with application to lung cancer diagnosis. Biosens Bioelectron Zhou T, Wang Z, Deng Y, Sun Y, Xue M, Bo B, Wang Z, Li G. PMID: 42987517 [PubMed - as supplied by publisher]
	Assessment of algorithmic performance in PET-CT segmentation of solitary lung tumors. PLoS One Le DT, Szabó D, Aranyi S, Mikó M, Képes Z, Mihovk I, Kovács AR, Nagy IG, Farkas B, Hajdú I, Trencsényi G, Trón L, Emri M, Opposits G. PMID: 42986831 [PubMed - indexed for MEDLINE]
	Molecular Testing Among Patients With Advanced Non-Small Cell Lung Cancer in the Rural US. JAMA Netw Open Rhinehart DP, van Gelderen E, Feliciano J, Pollack CE, Marrone KA, Blackford AL. PMID: 42986646 [PubMed - indexed for MEDLINE]
	HB0025 With Chemotherapy for Advanced Non-Small Cell Lung Cancer: A Phase 2 Nonrandomized Clinical Trial. JAMA Oncol Zhou F, Wang L, Bai J, Yang F, Sun M, Wang Q, Gao S, Yu G, Yao Y, Shi J, Zang A, Jiang X, Zhou J, Song X, Zhu X, Xu B, Zhan Y, Cui X, Ma X, Li B, Wang J, Cai Y, Zhou C. PMID: 42986615 [PubMed - as supplied by publisher]
	Comparison of Two Deep Learning Models and Their Combination for 1-year Lung Cancer Detection in Two Screening Cohorts. Radiol Cardiothorac Imaging Reeves AP, Mozafary M, Hashemi A, Atlas K, Zhang C, Atlas T, Azimi A, Mirjalili SR, Yip R, Vliegenthart R, de-Torres JP, Neder JA, González J, Seijo LM, Henschke C, Yankelevitz D, Naghavi M. PMID: 42986194 [PubMed - indexed for MEDLINE]
	Qualitative Insights From Public Interviews in the United Kingdom on the Acceptability of Risk-Based Eligibility Criteria for Lung Cancer Screening. Health Expect Katsampouris E, Hutton G, Scott SE, Duffy SW, Johansson M, Robbins HA, Quaife SL. PMID: 42985846 [PubMed - indexed for MEDLINE]
	Cardiovascular biomarker phenotype associated with immune checkpoint inhibitor therapy in patients with non-small cell lung cancer: an exploratory blood transcriptome study. Front Immunol Ziemska-Legi, , Borucka M, Kaczmarska D, Zaborowska-Szmit M, Ozdowska P, Zajda K, Janowicz-, D, Serementa L, Orlowski TM, Krzakowski M, Szmit S, Mikula M, Ostrowski J, Jagielska B. PMID: 42985563 [PubMed - indexed for MEDLINE]
	The consolidation paradox: rethinking thoracic radiotherapy in extensive-stage small cell lung cancer in the immunotherapy era. Front Oncol Ciammella P, Alì E, Iori F. PMID: 42985426 [PubMed]
	Case Finding for COPD in Nottingham and District (C FIND COPD). A Pilot Study of Uptake, Acceptability and Diagnostic Yield in a One-Stop Assessment Following Lung Cancer Screening. Int J Chron Obstruct Pulmon Dis Burzic A, Hamrouni M, Porte J, Gupta A, Murray RL, McKeever TM, O'Dowd E, Bolton CE. PMID: 42985238 [PubMed - indexed for MEDLINE]
	Immune checkpoint inhibitor-induced multi-organ immune damage complicated by severe pneumonia: case report. Front Immunol Zhao T, Chen R, Ma Y, Li G, Gu X, Chen Y, Sun H. PMID: 42984913 [PubMed - indexed for MEDLINE]
	CT-based prediction of EGFR mutation subtypes and TP53 co-mutation status in lung adenocarcinoma. Front Mol Biosci Liu H, Li Z, Zhang Y, Yu G, Miao Y, Teng X, Xu Y, Xu W, Gao C, Bai F, Li L. PMID: 42984794 [PubMed]
	Two case reports of small cell lung cancer: typical CT manifestations, with one case illustrating adjunctive CT-based diagnosis without pathological confirmation. Front Oncol Zhu Y, Wang Q, Yu M, Qin Y, Sun L, Ye M, Li J, Huang H. PMID: 42984569 [PubMed]
	Development and validation of a nomogram for predicting 5-year progression-free survival probability in differentiated thyroid cancer patients with lung metastases. Front Endocrinol (Lausanne) Wang C, Zhang X, Zhang Y, Liu J, Qin G, Han P, Li Y, Wang R, Wang X. PMID: 42984522 [PubMed - indexed for MEDLINE]
	The relationship between preoperative anxiety, self-efficacy, and positive coping style in lung cancer patients undergoing video-assisted thoracoscopic surgery: a cross-sectional study. BMC Psychol Zhang S, Cheng L, Guo H, Wang Z, Li Y, Qiao L, Chen A, Lai C, Li J, Gao X, He Z. PMID: 42983868 [PubMed - indexed for MEDLINE]
	Advanced lung cancer inflammation index predicts in-hospital mortality and refines risk stratification in patients with cirrhosis. BMC Gastroenterol Zhao Y, Peng X, Song L. PMID: 42983631 [PubMed - indexed for MEDLINE]
	Clinicopathologic and prognostic value of HER2 alterations in non-small cell lung cancer. Respir Res Lin Y, Xue Q, Zhang B, Wang Y, Zheng Q, Jin Y, Li Y. PMID: 42983529 [PubMed - indexed for MEDLINE]
	Exercise-induced metabolic reprogramming in lung cancer and its translational implications for therapeutic advancement. J Transl Med Zheng Y, Chen Y, Zhao H, Wu G, Hua C, Gao F, Liu Y, Jiang L, Dai L. PMID: 42983451 [PubMed - indexed for MEDLINE]
	Integrated analysis identifies an aging-related prognostic signature for lung adenocarcinoma. BMC Cancer Zhang R, Chen X, Li N, Peng M. PMID: 42983362 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 164341

Seite 1 von 8218



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung